Resignation of Ms. Pratibha Jhawar from the post of Company Secretary & Compliance officer.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts less than Nifty Microcap 250 and 2.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Ms. Pratibha Jhawar has resigned from the post of Company Secretary and Compliance Officer of Venmax Drugs and Pharmaceuticals Ltd, effective April 21, 2025. The resignation, cited as due to personal reasons, was accepted by the Board of Directors at its meeting held on the same day, which ran from 11:00 AM to 11:50 AM. The company has disclosed the details as required under SEBI Listing Regulations. No reason beyond 'personal reasons' has been provided, and no replacement has been announced in this filing.
The Company Secretary is a Key Managerial Personnel, and her sudden departure may raise short-term governance and compliance concerns for shareholders until a replacement is appointed. The stock price impact is likely minimal unless succession delays trigger further disclosures.